1 Subjects: “...Biological Products / therapeutic use...”

2 Subjects: “...Biological Products / therapeutic use...”

3 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

4 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

5 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

6 “...In 2017, CADTH produced a Rapid Response report summarizing evidence on the clinical effectiveness...”

7 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

8 “...In 2017, CADTH produced a Rapid Response report summarizing evidence on the clinical effectiveness...”

9 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

10 “...), and received a recommendation of "do not list". CADTH has previously produced a Rapid Response Summary...”

11 “... the time needed for normal tissue healing. It can impact the individual's quality of life and productivity...”

12 “... the time needed for normal tissue healing. It can impact the individual's quality of life and productivity...”

13 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

14

15

16 “...), and received a recommendation of "do not list". CADTH has previously produced a Rapid Response Summary...”

17 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

18 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

19

20